[go: up one dir, main page]

HK1242195B - 治疗疾病的组合疗法 - Google Patents

治疗疾病的组合疗法 Download PDF

Info

Publication number
HK1242195B
HK1242195B HK18101619.9A HK18101619A HK1242195B HK 1242195 B HK1242195 B HK 1242195B HK 18101619 A HK18101619 A HK 18101619A HK 1242195 B HK1242195 B HK 1242195B
Authority
HK
Hong Kong
Prior art keywords
instances
antibody
seq
dll4
agent
Prior art date
Application number
HK18101619.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1242195A1 (zh
Inventor
Lamond MURRIEL Christopher
Charles Hoey Timothy
L. Gurney Austin
Michelle RODA Julie
K. SRIVASTAVA Minu
PARK Inkyung
Dupont Jakob
Original Assignee
Mereo Biopharma 5, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mereo Biopharma 5, Inc. filed Critical Mereo Biopharma 5, Inc.
Publication of HK1242195A1 publication Critical patent/HK1242195A1/zh
Publication of HK1242195B publication Critical patent/HK1242195B/zh

Links

HK18101619.9A 2014-10-31 2015-10-30 治疗疾病的组合疗法 HK1242195B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62/073,634 2014-10-31
US62/127,172 2015-03-02
US62/192,133 2015-07-14
US62/242,567 2015-10-16

Publications (2)

Publication Number Publication Date
HK1242195A1 HK1242195A1 (zh) 2018-06-22
HK1242195B true HK1242195B (zh) 2021-04-09

Family

ID=

Similar Documents

Publication Publication Date Title
US20250179169A1 (en) Combination therapy for treatment of disease
JP7203446B2 (ja) Ｔｉｇｉｔ結合物質およびその使用法
US10232017B2 (en) Method of treating cancer by administering tumor necrosis factor receptor ligand superfamily (TNFRSF) single-chain polypeptides
US20180346571A1 (en) Pd-l1-binding agents and uses thereof
US20180222958A1 (en) Lymphotoxin-beta receptor-binding agents, targeting antibodies, and uses thereof
WO2018017864A2 (en) Pvrig-binding agents and uses thereof
WO2018027025A1 (en) Cd40-binding agents and uses thereof
US20190048094A1 (en) Redirecting immune responses
WO2017040660A1 (en) Combination therapy for treatment of disease
WO2017040666A2 (en) Combination therapy for treatment of disease
WO2019032945A1 (en) CD40 BINDING AGENT AND USES THEREOF
HK1242195B (zh) 治疗疾病的组合疗法
HK1242195A1 (zh) 治疗疾病的组合疗法
HK40075836A (zh) Tigit結合劑及其用途